Alprostadil (Caverject/MUSE) Cost in Kansas 2026

What Does Alprostadil Cost in Kansas Without Insurance?

Without insurance, alprostadil runs about $600 per month at Kansas retail pharmacies in 2026, whether you choose Caverject (intracavernosal injection) or MUSE (intraurethral suppository). That price tracks the manufacturer list price set by Pfizer and generic manufacturers. Cash-pay patients at chains like Walgreens, CVS, and independent Kansas pharmacies typically see little deviation from that figure unless they use a discount card.

Alprostadil is prostaglandin E1, a naturally occurring lipid compound that relaxes cavernous smooth muscle and dilates penile arteries. In the key Linet et al. randomized controlled trial published in the New England Journal of Medicine (N=296), alprostadil intracavernosal injection produced erections sufficient for intercourse in 94.4% of treatment attempts compared with 10.9% for placebo (P<0.001) 1. That efficacy record is why alprostadil remains a guideline-supported second-line therapy for erectile dysfunction even decades after approval.

Generic alprostadil injection kits became more widely available after Caverject's core patents expired, but manufacturing complexity keeps retail prices high. GoodRx and similar discount platforms list Kansas prices for a 6-unit Caverject Impulse kit (20 mcg) at $520 to $680 depending on pharmacy location and coupon applied 2. MUSE suppositories (10-pack, 500 mcg) sit in a similar range. Neither form has experienced the steep price drops seen with orally absorbed generics like sildenafil.

Purchasing alprostadil always requires a valid prescription from a licensed prescriber. The FDA-approved labeling for Caverject specifies that the drug is for intracavernosal use only and that patients must receive injection training before self-administration 3. Skipping that training step is a safety risk, not just a regulatory formality, because incorrect injection technique raises the risk of priapism and penile fibrosis.

Does Kansas Medicaid Cover Alprostadil?

Kansas Medicaid (KanCare) does not cover alprostadil for erectile dysfunction in the general adult population. The state carves out coverage for a narrow subset of beneficiaries with documented organic erectile dysfunction secondary to specific comorbidities, and type 2 diabetes is the most commonly cited qualifying condition in state drug-coverage policy documents. Even within that subset, prior authorization requirements are strict and approvals are rare.

This coverage gap mirrors a broader national pattern. The Centers for Medicare and Medicaid Services have long treated drugs for sexual dysfunction as lifestyle medications rather than medically necessary treatments, a classification that cascades into most state Medicaid formularies 4. Kansas follows that federal lead. Adult beneficiaries on standard KanCare managed-care plans (Aetna Better Health, Sunflower Health Plan, United Healthcare Community Plan) should expect a denial on first submission unless a physician documents that the ED is directly caused by a covered condition and that oral PDE5 inhibitors have failed or are contraindicated.

Medicare Part D similarly excludes erectile dysfunction drugs from standard coverage, meaning older Kansas men on dual Medicare-Medicaid coverage face the same wall from both programs 5. Some Part D plans offer supplemental benefits that partially offset the cost, but those plans are not universal and require annual formulary verification.

Patients who receive a denial should request a written Explanation of Benefits and ask their prescriber to submit a peer-to-peer review. Documented PDE5 inhibitor failure, a relevant organic diagnosis (spinal cord injury, post-prostatectomy nerve damage, severe peripheral neuropathy), and chart notes showing sexual dysfunction's impact on quality of life all strengthen an appeal.

Is Compounded Alprostadil Legal in Kansas?

Compounded alprostadil is legal in Kansas when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Kansas follows the federal framework established by the Drug Quality and Security Act of 2013, which permits 503A pharmacies to compound alprostadil for individual patients when a licensed prescriber identifies a clinical need not met by a commercially available product 6.

Common reasons a prescriber may specify compounded alprostadil include dose customization (the commercial products come in fixed concentrations), combination formulations such as alprostadil plus papaverine plus phentolamine (the "trimix" approach), and documented patient sensitivity to an excipient in the brand product. Kansas pharmacies offering compounded intracavernosal preparations include both local compounders and mail-order 503A pharmacies that ship to Kansas addresses legally.

Cost is the most frequently cited reason patients ask about compounded alprostadil. A compounded trimix or alprostadil-only preparation from a 503A pharmacy can cost considerably less than the $600 retail benchmark for brand or generic commercial product, though exact pricing varies by formulation strength and pharmacy overhead. Patients should confirm that any pharmacy they choose holds an active Kansas Board of Pharmacy license and, for sterile preparations, meets USP Chapter 797 sterile compounding standards 7.

Compounded alprostadil is not FDA-approved. The FDA has not evaluated it for safety or efficacy in the same way it reviewed Caverject or MUSE. That does not make it illegal under 503A, but it does mean the prescriber and patient share responsibility for understanding that the quality assurance path differs from that of a branded product.

Can You Get Alprostadil via Telehealth in Kansas?

Yes. Kansas allows telehealth prescribing of alprostadil. A licensed Kansas prescriber conducting a synchronous audio-video visit may evaluate a patient for erectile dysfunction and write a valid alprostadil prescription without an in-person encounter, provided the clinical evaluation meets the standard of care 8. Kansas law does not require a prior in-person visit for most controlled substances except Schedule II opioids and benzodiazepines, and alprostadil is not a controlled substance, making telehealth access relatively straightforward.

Telehealth is broadly consistent with the American Urological Association's 2018 guidelines on erectile dysfunction, which state that clinicians should obtain a medical, psychosocial, and sexual history and perform a focused physical examination. A thorough telehealth visit can satisfy the history and many examination elements. Where pelvic or genital examination findings are clinically necessary, the prescriber may request that the patient complete those components with a local primary care provider before a prescription is issued 9.

For patients in rural Kansas counties, telehealth closes a meaningful access gap. The nearest urology specialist from western Kansas towns like Dodge City or Liberal may be 90 to 120 minutes away. A telehealth visit with a Kansas-licensed urologist or sexual medicine prescriber can generate a prescription that a local retail pharmacy or a mail-order 503A compounder then fills. That path is both legal and practical.

After receiving the prescription, patients still need in-person injection training if they choose Caverject or a compounded intracavernosal preparation. Some telehealth platforms coordinate this training through partnering local clinics or urological nursing services. MUSE suppositories involve a less invasive administration route and may require less hands-on training, though the prescriber should confirm patient technique before unsupervised use.

Which Insurance Plans Cover Alprostadil in Kansas?

Commercial insurance coverage for alprostadil in Kansas is inconsistent and plan-specific. Most large employer-sponsored plans (BCBS Kansas, Aetna, Cigna, United Healthcare, Humana) classify alprostadil under their specialty or non-preferred tier, meaning it is covered only with prior authorization and after step therapy requirements are met 10.

Step therapy almost always requires documented failure of at least one, and often two, oral PDE5 inhibitors (sildenafil, tadalafil, vardenafil, or avanafil) before alprostadil is approved. The clinical rationale is cost: generic sildenafil now retails for as little as $1 to $4 per tablet in Kansas, making it a substantially cheaper first-line option. Alprostadil's higher price point means insurers reserve it for patients who cannot use or did not respond to oral therapy.

When prior authorization is approved, Kansas plans typically cover Caverject or its generic equivalent at the patient's specialty tier copay, which runs $50 to $150 per fill depending on the plan's cost-sharing structure. MUSE suppositories face similar tier placement. ACA marketplace plans sold in Kansas are not required to cover erectile dysfunction drugs at all, and many exclude them entirely.

Veterans enrolled in the Kansas VA system (Wichita VAMC, Fort Leavenworth, Salina CBOC) have a different pathway. The VA National Formulary includes alprostadil for veterans with service-connected or documented organic erectile dysfunction, subject to a VA prescriber's order. VA copays are substantially lower than retail prices for eligible veterans 11.

What Is the Cheapest Way to Get Alprostadil in Kansas?

The three lowest-cost paths for Kansas patients in 2026 are: a manufacturer savings program, a compounded 503A preparation, or a GoodRx-style discount card at a high-volume pharmacy. Each path has trade-offs.

Pfizer's Caverject patient assistance program (PAP) accepts applicants whose household income falls below 400% of the federal poverty line and who lack insurance coverage for the drug. Approved patients may receive Caverject at no cost or reduced cost directly from Pfizer. The application requires a prescriber signature, proof of income, and a denial letter from any applicable insurance 12. Processing takes two to four weeks.

Compounded alprostadil from a licensed Kansas 503A pharmacy typically offers the greatest cost reduction for patients who do not qualify for the PAP and whose insurance denies coverage. Because 503A pharmacies set their own pricing, patients should call at least three pharmacies and compare quotes for an equivalent strength and supply. A 10-dose vial of compounded alprostadil at 10 mcg/0.5 mL can range from $40 to $120 depending on the pharmacy, representing a 75% to 90% reduction from the brand list price.

GoodRx and RxSaver discount cards reduce the retail cash price at Kansas pharmacies by 10% to 25% for generic alprostadil injection kits. That still leaves patients paying $450 to $540 per month, so discount cards are most useful for patients who need one or two doses while waiting for a PAP or prior authorization decision.

The HealthRX Cost Navigation Framework for Kansas alprostadil patients:

1. Check insurance formulary and submit prior authorization with documented PDE5 inhibitor failure.
2. If denied, apply to Pfizer PAP if income-eligible.
3. If ineligible for PAP or awaiting PAP approval, request a compounded alprostadil prescription and contact three Kansas 503A pharmacies for pricing.
4. Use a GoodRx card only as a bridge, not a permanent solution.
5. Veterans: contact the Wichita VAMC pharmacy before pursuing any retail option.

How Alprostadil Works and Why Dose Matters for Cost

Understanding how alprostadil works helps explain why dosing is not one-size-fits-all and why the dose you need directly affects your monthly cost. Alprostadil is prostaglandin E1 (PGE1). It binds EP2 and EP3 receptors on cavernous smooth muscle cells, activates adenylyl cyclase, raises intracellular cyclic AMP, and causes smooth muscle relaxation. Blood flows into the lacunar spaces of the corpora cavernosa faster than venous outflow can remove it, producing an erection 13.

The FDA-approved Caverject dose range is 1.25 mcg to 60 mcg per injection. Most men find their effective dose between 5 mcg and 20 mcg after a titration process conducted in a prescriber's office. Men who require 40 mcg or 60 mcg doses use roughly three to four times as much drug per event as men who respond to 10 mcg. Because Caverject Impulse kits are sold by unit dose, not by total alprostadil weight, a patient needing 40 mcg may go through a kit twice as fast as a patient needing 20 mcg, which doubles the effective monthly cost 14.

MUSE suppositories come in four strengths: 125 mcg, 250 mcg, 500 mcg, and 1 to 000 mcg. The Linet et al. trial found that 64.9% of at-home MUSE uses resulted in an erection sufficient for intercourse, lower than intracavernosal injection rates but with a substantially lower adverse event profile 1. Men who respond to 250 mcg MUSE pay less per dose than those requiring the 1 to 000 mcg suppository, so effective titration to the lowest working dose matters economically as well as clinically.

Penile pain is the most common adverse effect, reported in 31% to 37% of intracavernosal injection patients and 32% of MUSE users in clinical studies 15. Priapism (erection lasting more than four hours) occurs in fewer than 1% of patients at correctly titrated doses but is a medical emergency requiring immediate care. Kansas patients should know that the nearest 24-hour emergency departments in Wichita, Topeka, Kansas City (KS), and Manhattan can manage priapism with intracavernosal phenylephrine injection per AUA protocol.

Alprostadil Discount Programs and Savings Cards in Kansas

Pfizer offers a Caverject savings card for commercially insured patients that can reduce the copay to as low as $0 for eligible fills, subject to a maximum annual benefit cap (historically $2,400 per year). The card is not valid for patients enrolled in Medicare, Medicaid, or any federal or state government insurance program, including VA benefits 16. Kansas patients can activate the Pfizer savings card at the point of sale at most major Kansas retail pharmacies.

Generic alprostadil manufacturers (Sun Pharmaceutical, Mylan/Viatris) do not consistently offer branded savings cards, but their products are eligible for GoodRx and NeedyMeds discount codes at Kansas pharmacies. The NeedyMeds patient assistance database also lists income-based programs for alprostadil that fall outside the Pfizer PAP, including some hospital-based charity programs at University of Kansas Health System and Stormont Vail Health in Topeka 17.

Kansas patients who qualify for the federal 340B Drug Pricing Program through a qualifying health center can access alprostadil at 340B ceiling prices. Federally Qualified Health Centers (FQHCs) across Kansas, including Heartland Community Health Center (Manhattan), GraceMed Health Clinic (Wichita), and Salud (Dodge City), participate in 340B and can prescribe and dispense alprostadil at substantially reduced cost to eligible patients 18.

The 340B path requires that both the prescriber and the dispensing pharmacy are part of the covered entity's program. Patients should ask their FQHC provider directly whether alprostadil is on the center's 340B formulary, as not every 340B entity stocks specialty injectables.

Clinical Context: Who Is a Candidate for Alprostadil in Kansas?

Alprostadil is FDA-approved for erectile dysfunction in adult men. The AUA and the Sexual Medicine Society of North America position it as a second-line monotherapy after oral PDE5 inhibitors fail or are contraindicated 9. Contraindications to PDE5 inhibitors include concurrent nitrate use (any route), severe hypotension, and certain retinal disorders, so a subset of men with cardiovascular disease move directly to alprostadil as first-line therapy.

Post-prostatectomy erectile dysfunction is a common indication in Kansas urology practices. After radical prostatectomy, penile rehabilitation protocols at centers like the University of Kansas Health System and Stormont Vail use low-dose intracavernosal alprostadil (2.5 mcg to 5 mcg) starting four to eight weeks post-surgery to preserve smooth muscle oxygenation and prevent corporal fibrosis while nerve recovery occurs 19. That indication is well-supported by data: a randomized trial by Montorsi et al. (N=30) found that early intracavernosal alprostadil after nerve-sparing prostatectomy produced spontaneous erection recovery in 67% of treated patients versus 20% of controls at six months 20.

Diabetic erectile dysfunction, spinal cord injury, and Peyronie's disease-associated ED are additional indications where alprostadil has strong clinical support and where Kansas prescribers regularly choose it over oral agents.

Men with sickle cell anemia, leukemia, multiple myeloma, or anatomical penile deformity should not use alprostadil due to risk of priapism or mechanical complications. Kansas prescribers are expected to screen for these conditions before prescribing.

How to Get a Prescription for Alprostadil in Kansas

A prescription requires evaluation by a licensed Kansas prescriber: a urologist, sexual medicine specialist, men's health physician, or in many cases, a primary care provider. The evaluation should include a detailed sexual and medical history, a review of current medications (screening for nitrate use, alpha-blockers, and anticoagulants), and a physical exam or a telehealth-compatible equivalent 9.

Kansas telehealth platforms that specialize in men's health can complete the evaluation during a single video visit, typically lasting 20 to 30 minutes. The prescriber will assess whether PDE5 inhibitor failure is documented or whether an immediate second-line approach is warranted. Lab work is not always required but may include testosterone, prolactin, fasting glucose, and lipid panel to identify reversible hormonal or metabolic contributors to ED 9.

Once the prescription is written, the patient selects a fill location: a Kansas retail pharmacy for brand or generic commercial product, a licensed Kansas 503A compounding pharmacy for customized formulations, or a mail-order 503A compounder shipping to a Kansas address. First-time Caverject users must receive dose-titration training and injection technique instruction from a healthcare provider before self-administering at home.

The FDA label specifies that the initial dose should be administered in a medical setting, with the patient observed for at least 30 minutes for hemodynamic response and priapism before discharge 14. Dose is then adjusted up or down based on that first response, and a final self-injection dose is confirmed in the office before home use begins. MUSE requires a similar in-office first dose with a 30-minute observation window per FDA labeling.

At the correct titrated dose, 94% of intracavernosal injection attempts and 65% of MUSE attempts produced clinically adequate erections in the foundational trials 1. Kansas men starting alprostadil in 2026 can expect similar efficacy when dosing is properly individualized.